{"SPADE_N_07176": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07176", "Peptide Name": "Fibrinogen derived", "Source": "Fibrinogen", "Family": "", "Gene": "Not found", "Sequence": "ARPAKAAATQKKVERKAPDA", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "αvβ3", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C90H159N31O27", "Mass": 2107.42, "PI": 10.45, "Net Charge": 4, "Hydrophobicity": -1.11, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-17.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "AKP", "Absent Amino Acids": "CFGHILMNOSUWY", "Basic Residues": 6, "Acidic Residues": 2, "Hydrophobic Residues": 10, "Polar Residues": 16, "Positive Residues": 6, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06020", "Similarity": 0.7142857142857143, "Sequence": "KAAAKAAKAA"}, {"SPADE_ID": "SPADE_UN_07944", "Similarity": 0.6666666666666666, "Sequence": "AKAAPAKAKAP"}, {"SPADE_ID": "SPADE_UN_01049", "Similarity": 0.6666666666666666, "Sequence": "KKAAAKAAAAAKAAWAAKAAAKKKK"}]}}}